Study shows first applications of DNA origami for nanomedicine Continue reading→

The Center for Advancing Innovation and MedImmune have partnered to launch the Freedom from Cancer Startup Challenge (FCSC). The FCSC will feature risk mitigated, and commercially viable inventions from leading research organizations. Continue reading→

Joan Koerber-Walker, president & CEO of AZBio, joined Bob Roth, Managing Partner of Cypress Homecare Solutions, to discuss the exciting things happening in Arizona’s bioscience and healthcare community on HEALTH FUTURES radio show.Continue reading→

Phoenix, AZ— bioSyntagma, LLC, a developer of life science tools for single and multi-cell analysis announced today it has been has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant of $735,139.Continue reading→

SMS archiving technology patented by CellTrust is fundamental for successful e-compliance enforcement for the highly regulated financial services, government and healthcare industries.Continue reading→

A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.Continue reading→

A Tempe bioscience firm selling its DNA analysis kits to 25 countries worldwide is expanding into the education sector.Continue reading→

NuvOx Pharma, a clinical stage biotechnology company, announces that the FDA has allowed a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Continue reading→